ReviewTherapeutic advances in hematology2025

Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia.

Malin S Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.